|
TAKAGI Toshio
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Professor and Division head |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. |
| Journal | Formal name：The New England journal of medicine Abbreviation：N Engl J Med ISSN code：00284793/15334406 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 384(14),pp.1289-1300 |
| Author and coauthor | Robert Motzer , Boris Alekseev , Sun-Young Rha , Camillo Porta , Masatoshi Eto , Thomas Powles , Viktor Grunwald , Thomas E Hutson , Evgeny Kopyltsov , Maria J Mendez-Vidal , Vadim Kozlov , Anna Alyasova , Sung-Hoo Hong , Anil Kapoor , Teresa Alonso Gordoa , Jaime R Merchan , Eric Winquist , Pablo Maroto , Jeffrey C Goh , Miso Kim , Howard Gurney , Vijay Patel , Avivit Peer , Giuseppe Procopio , TAKAGI Toshio, Bohuslav Melichar , Frederic Rolland , Ugo De Giorgi , Shirley Wong , Jens Bedke , Manuela Schmidinger , Corina E Dutcus , Alan D Smith , Lea Dutta , Kalgi Mody , Rodolfo F Perini , Dongyuan Xing , Toni K Choueiri , CLEAR Trial Investigators |
| Publication date | 2021/04 |
| DOI | 10.1056/NEJMoa2035716 |
| PMID | 33616314 |